Understanding and preventing sarcopenia
As it ages, the body weakens. This is due, in particular, to the loss of muscle mass as well as muscle quality. This phenomenon was only objectified (and named) in 1989, which led to scientific interest in the subject. “The medical and scientific world are now more interested in sarcopenia but due to the fact that very few studies have been devoted to this geriatric syndrome and its consequences in the short, medium and long term, there is very little epidemiological data available on the subject”, laments Professor Olivier Bruyère, of the Public Health, Epidemiology and Health Economics service of the University of Liege. This is why the University of Liege has initiated the SarcoPhAge study (for Sarcopenia and Physical Impairments with Advancing Age) which has yielded its first results(1). The SarcoPhAge studyIt was for this purpose that the SarcoPhAge study was set up by the University of Liege. Between June 2013 and June 2014, 534 people over the age of 65 volunteered to take part in the study. “The participants were recruited by means of the press and by consultation with the different departments in the University Hospital of Liege. We were surprised by the number of volunteers who were willing to take part in the study”, said a delighted Charlotte Beaudart. All the participants were given some questionnaires to complete on their sociodemographic and medical profile as well as their lifestyle. Several parameters were then listed. “Evidently, muscle mass was measured in the individuals concerned as well as muscle strength or physical performance, which are the traditional parameters used to evaluate sarcopenia. However, we used tools that are currently recommended for evaluating sarcopenia. So, in order to measure muscle mass we used Dual-energy X-ray absorptiometry or DXA, which makes it possible to distinguish “lean” mass (including that of the muscles) from fat mass and bone mineral density. From the appendicular lean mass obtained, we were able to determine a skeletal muscle mass index for each individual studied, which, together with other tests, makes it possible to diagnose sarcopenia”, explains Professor Olivier Bruyère. ![]() (1) Beaudart C., Reginster J-Y., Petermans J., Gillain S., Quabron A., Locquet M., Slomian J., Buckunx F., Bruyère O., Quality of life and physical components linked to sarcopenia : The SarcoPhAge study, Experimental gerontology, 69, 103-110, 2015 |
|
||||||||||||||||||
© 2007 ULi�ge
|
||